Placeholder Banner

BIO Congratulates Dr. Robert Califf on Confirmation as FDA Commissioner

February 24, 2016

Washington, D.C. (February 24, 2016) – The following statement may be attributed to Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood:

“BIO extends our congratulations to Dr. Califf on his confirmation as Commissioner of the FDA, a job that carries tremendous responsibility in protecting public health and advancing biotechnology innovation. Dr. Califf’s confirmation comes at a time of tremendous advances being made in biotechnology and regulatory science, and I am confident that he will provide the stability, leadership and confidence the public seeks from an agency entrusted with such a critical mission.

“We applaud Chairman Alexander and Ranking Member Murray for their bi-partisan leadership and cooperation throughout Dr. Califf’s confirmation process. We look forward to working with Dr. Califf to ensure that the FDA’s regulatory capabilities and science continue to keep pace with the tremendous progress taking place in biotechnology innovation.”

Upcoming BIO Events 

BIO International Convention
June 6-9, 2016
San Francisco, Calif.

13th Annual BIO Asia International Conference
March 15-16, 2016
Tokyo, Japan

World Congress on Industrial Biotechnology
San Diego, CA
April 17-20, 2016

BIO-Europe Spring
April 4-6, 2016
Stockholm, Sweden


###

 

Discover More
Action plan outlines the policies needed to ensure that the biotechnology sector remains a driving force for America’s health, prosperity, national security, and geopolitical strengthWASHINGTON (November 10, 2026) - The Biotechnology Innovation…
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.WASHINGTON, DC & SAN DIEGO, CA & SAN FRANCISCO, CA - The…
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact…